News | SK Capital

All News

Genetix

Genetix Biotherapeutics and SPIMACO Announce Strategic Agreement to Commercialize and Manufacture LYFGENIA™ & ZYNTEGLO™ in Saudi Arabia and the Broader Middle East Region

June 23, 2026

Apotex

Apotex Health Corp. Announces Closing of Upsized Initial Public Offering and Exercise of Over-Allotment Option in Full

June 16, 2026

Isolatek

SK Capital Completes the Sale of Isolatek International to Catchment Capital

June 10, 2026

Acquisitions, Swixx

Swixx Completes Strategic Investment From SK Capital and Bain Capital Life Sciences to Support Continued Global Expansion

June 1, 2026

Halo Pharmaceutical

Halo Pharma Emerges as Standalone CDMO Following Siegfried Acquisition of Noramco

May 8, 2026

Phoenix

SK Capital Partners Completes the Sale of Phoenix Flavors & Fragrances to Turpaz Industries

May 4, 2026

Load More